{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:53:02Z","timestamp":1791175982472,"version":"4.1.0"},"reference-count":19,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2026.13293","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:59:26Z","timestamp":1789106366000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Reversible osimertinib\u2011associated heart failure mimicking cancer recurrence in\n                    <i>EGFR<\/i>\n                    \u2011mutated non\u2011small cell lung cancer after pneumonectomy: A case report"],"prefix":"10.3892","volume":"32","author":[{"given":"Hirona","family":"Yokoyama","sequence":"first","affiliation":[{"name":"Center for Postgraduate Training, Nara Medical University Hospital, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhito","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Yoshii","sequence":"additional","affiliation":[{"name":"Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Hamaji","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nitta","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"key20261005073142_b1-ETM-32-5-13293","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N Engl J Med"},{"key":"key20261005073142_b2-ETM-32-5-13293","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in resected EGFR-mutated non-small-cell lung cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N Engl J Med"},{"key":"key20261005073142_b3-ETM-32-5-13293","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1056\/NEJMoa1612674","article-title":"Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer","volume":"376","author":"Mok","year":"2017","journal-title":"N Engl J Med"},{"key":"key20261005073142_b4-ETM-32-5-13293","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1158\/2159-8290.CD-14-0337","article-title":"AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer","volume":"4","author":"Cross","year":"2014","journal-title":"Cancer Discov"},{"key":"key20261005073142_b5-ETM-32-5-13293","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaccao.2020.02.003","article-title":"Cardiac adverse events in EGFR-mutated non-small cell lung cancer treated with osimertinib","volume":"2","author":"Kunimasa","year":"2020","journal-title":"JACC CardioOncol"},{"key":"key20261005073142_b6-ETM-32-5-13293","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N Engl J Med"},{"key":"key20261005073142_b7-ETM-32-5-13293","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"Erlotinib in previously treated non-small-cell lung cancer","volume":"353","author":"Shepherd","year":"2005","journal-title":"N Engl J Med"},{"issue":"e2448364","key":"key20261005073142_b8-ETM-32-5-13293","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.48364","article-title":"Cardiac events and survival in patients with EGFR-mutant non-small cell lung cancer treated with osimertinib","volume":"7","author":"Lin","year":"2024","journal-title":"JAMA Netw Open"},{"key":"key20261005073142_b9-ETM-32-5-13293","first-page":"5749","article-title":"ZD1839 (Iressa): An orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy","volume":"62","author":"Wakeling","year":"2002","journal-title":"Cancer Res"},{"key":"key20261005073142_b10-ETM-32-5-13293","first-page":"70","article-title":"Trastuzumab-induced cardiac dysfunction: A \u2018dual-hit\u2019","volume":"16","author":"Zeglinski","year":"2011","journal-title":"Exp Clin Cardiol"},{"issue":"3","key":"key20261005073142_b11-ETM-32-5-13293","doi-asserted-by":"publisher","DOI":"10.1186\/s40959-015-0006-7","article-title":"Cardiac safety of afatinib: A review of data from clinical trials","volume":"1","author":"Ewer","year":"2015","journal-title":"Cardiooncology"},{"key":"key20261005073142_b12-ETM-32-5-13293","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/eurheartj\/ehaf813","article-title":"Osimertinib induces reversible cardiac dysfunction through the GATA4-MYLK3-MYL2 axis","volume":"47","author":"Zhang","year":"2026","journal-title":"Eur Heart J"},{"key":"key20261005073142_b13-ETM-32-5-13293","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.toxlet.2024.05.005","article-title":"Transcriptomics coupled with proteomics reveals osimertinib-induced myocardial mitochondrial dysfunction","volume":"397","author":"Yang","year":"2024","journal-title":"Toxicol Lett"},{"key":"key20261005073142_b14-ETM-32-5-13293","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jtho.2024.10.003","article-title":"The risk and reversibility of osimertinib-related cardiotoxicity in a real-world population","volume":"20","author":"Bak","year":"2025","journal-title":"J Thorac Oncol"},{"issue":"1431023","key":"key20261005073142_b15-ETM-32-5-13293","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1431023","article-title":"Risk factors of osimertinib-related cardiotoxicity in non-small cell lung cancer","volume":"14","author":"Wang","year":"2024","journal-title":"Front Oncol"},{"key":"key20261005073142_b16-ETM-32-5-13293","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ejcts.2004.05.036","article-title":"Study on the late effect of pneumonectomy on right heart pressures using Doppler echocardiography","volume":"26","author":"Foroulis","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"key20261005073142_b17-ETM-32-5-13293","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.ejcts.2007.07.033","article-title":"Long-term Doppler echocardiographic evaluation of the right heart after major lung resections","volume":"32","author":"Venuta","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"key20261005073142_b18-ETM-32-5-13293","author":"Lumb"},{"key":"key20261005073142_b19-ETM-32-5-13293","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:31:46Z","timestamp":1791174706000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2026.13293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,11]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2026.13293","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}